Clinical Trial Update: Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of carboxyamidotriazole for metastatic renal cell carcinoma (recurrent or stage IV) conducted by the National Cancer Institute has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Carboxyamidotriazole (carboxyamidotriazole)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer | Phase 2 | Status: COMPLETED